Aviilx_long is a groundbreaking formulation to specifically target the Multiorgan system effects of COVID-19. Multiorgan system effects of COVID-19 have been documented in most, if not all, body systems including cardiovascular, pulmonary, renal, dermatologic, neurologic, and psychiatric. Multisystem inflammatory syndrome (MIS) and autoimmune conditions can also occur after COVID-19. Aviilx_long contains standardized botanical compounds that have been found to inhibit the effects of SARS-CoV-2 through multiple pathways including: anti-inflammatory, anti-viral and protecting against tissue and cell damage.*
Serving Size: 1 Capsule
Servings Per Container: 60
- Polygala tenuifolia (contains: standardized Tenuigenin) 40 mg †
- Gardenia jasminoides (contains: standardized Jasminoidin) 40 mg †
- Tryptophan 60 mg †
- Angelica keiskei (contains: standardized alkylated chalcones) 150 mg †
- Glycyrrhiza uralensis (contains: standardized Glycyrrhizin) 10 mg †
- Artemisia annua (contains: standardized Artemisinin (ART)) 50 mg †
- Scutellaria baicalensis (contains: standardized Baicalein) 50 mg †
- Luteolin 50 mg †
- Crocus sativus (Saffron) 50 mg †
† Daily Value not established.
Other Ingredients: Vegetable cellulose (hypromellose); Vegetable Stearic Acid; Microcrystalline Cellulose and Vegetable Magnesium Stearate.
DOES NOT CONTAIN: Wheat, gluten, soy, milk, eggs, fish, crustacean shellfish, tree nuts, peanuts.
1 capsules 2 times daily.
Pregnancy: It is possibly unsafe to take L-tryptophan in amounts greater than those found in foods during pregnancy. It might harm the unborn child.
Breast-feeding: There isn't enough reliable information to know if L-tryptophan is safe to use when breast-feeding.
SSRIs and SNRIs.
Caution with hypertension.
